Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that drive neovascular or "wet" age-related macular degeneration (nAMD) and diabetic macular edema (DME)The CHMP recommendation
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.The Elecsys HCV Duo
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two years. This represents an increase from 45% at year one Patients treated with Vabysmo received
Lunsumio (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma Application is based on results from the
The VENTANA DP 600 is Roche's new, high-capacity slide scanner that creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and determine a patient's treatment.Cancer